Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SAFEstart Treatment for NICU Patients With Feeding Intolerance; a Phase II Randomized, Controlled Trial

NCT00331201 is registered in ClinicalTrials.gov with Intermountain Health Care, Inc. as lead sponsor.

NCT NCT00331201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00331201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SAFEstart Treatment for NICU Patients With Feeding Intolerance; a Phase II Randomized, Controlled Trial
Lead sponsor
Intermountain Health Care, Inc.
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2005
Completion date
April 30, 2006
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal distention, blood in stool, emesis and diarrhea, feeding intolerance, gastric residual